Q4 2018 Holdings
Filed 2019-02-14 | 99 holdings | $283.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $55.8M | 6,910,789 | 19.6% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $45.3M | 472,000 | 16.0% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $43.6M | 5,893,416 | 15.3% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $31.6M | 505,098 | 11.1% |
| Brookdale SR Living Inc(BKD) | COM | 112463104 | $28.4M | 4,240,855 | 10.0% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $16.0M | 621,000 | 5.6% |
| Addus Homecare Corp(ADUS) | COM | 006739106 | $15.8M | 232,900 | 5.6% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $11.8M | 921,234 | 4.2% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $9.4M | 622,548 | 3.3% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $8.8M | 326,797 | 3.1% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $7.7M | 235,576 | 2.7% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $5.3M | 2,962,922 | 1.9% |
| Axogen Inc(AXGN) | COM | 05463X106 | $2.1M | 104,674 | 0.8% |
| Horizon Pharma PLC | SHS | G4617B105 | $133.4K | 6,825,719 | 0.0% |
| Orchard Therapeutics PLC | ADS | 68570P101 | $126.2K | 8,023,600 | 0.0% |
| Homology Medicines Inc | COM | 438083107 | $116.9K | 5,227,035 | 0.0% |
| Horizon Pharma Invt LTD | NOTE 2.500% 3/1 | 44052TAB7 | $112.7K | $113,532,000 | 0.0% |
| Nevro Corp | NOTE 1.750% 6/0 | 64157FAA1 | $92.3K | $100,000,000 | 0.0% |
| Mylan N V | SHS EURO | N59465109 | $77.6K | 2,833,741 | 0.0% |
| Dexcom Inc | NOTE 0.750% 5/1 | 252131AF4 | $73.7K | $55,000,000 | 0.0% |
| Vericel Corp(VCEL) | COM | 92346J108 | $64.8K | 3,725,900 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $60.4K | 1,386,541 | 0.0% |
| Intersect ENT Inc | COM | 46071F103 | $58.6K | 2,078,375 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $54.8K | 1,518,596 | 0.0% |
| Intercept Pharmaceuticals in | NOTE 3.250% 7/0 | 45845PAA6 | $53.0K | $57,791,000 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $48.7K | 997,000 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $47.4K | 743,439 | 0.0% |
| Xeris Pharmaceuticals Inc | COM | 98422L107 | $42.5K | 2,498,666 | 0.0% |
| Ehealth Inc(EHTH) | COM | 28238P109 | $41.4K | 1,076,402 | 0.0% |
| Kempharm Inc | NOTE 5.500% 2/0 | 488445AB3 | $39.4K | $65,423,000 | 0.0% |
| Universal Hlth Svcs Inc(UHS) | CL B | 913903100 | $38.7K | 332,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $37.3K | 341,800 | 0.0% |
| CVS Health Corp(CVS)Call | COM | 126650100 | $37.1K | 566,800 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $37.1K | 874,486 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $35.6K | 914,273 | 0.0% |
| Centene Corp del(CNC) | COM | 15135B101 | $33.0K | 286,000 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $32.7K | 1,677,414 | 0.0% |
| Wright MED Group N V | NOTE 2.250%11/1 | 98236JAB4 | $32.2K | $23,625,000 | 0.0% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $31.7K | 1,128,822 | 0.0% |
| Diplomat Pharmacy Inc(DPLOEUR) | COM | 25456K101 | $31.6K | 2,348,993 | 0.0% |
| Glaukos Corp(GKOS) | COM | 377322102 | $28.3K | 504,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $28.1K | 521,000 | 0.0% |
| RA Pharmaceuticals Inc | COM | 74933V108 | $27.3K | 1,502,000 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $26.5K | 288,407 | 0.0% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $26.4K | 1,158,841 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $26.2K | 1,833,202 | 0.0% |
| DFB Healthcare Acquistion Co | UNIT 01/30/2023 | 23291E208 | $25.3K | 2,500,000 | 0.0% |
| Anthem Inc(ELV) | COM | 036752103 | $25.0K | 95,000 | 0.0% |
| Allergan PLC | SHS | G0177J108 | $24.1K | 180,000 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $21.2K | 1,654,865 | 0.0% |